Pharma and Academia: What We Have Here Is a Failure to Communicate

In recent years, there has been substantial interest in the potential value of collaboration between academia and the pharmaceutical industry. In this Crosstalk, I discuss obstacles to these relationships being optimally productive. In recent years, there has been substantial interest in the potenti...

Full description

Saved in:
Bibliographic Details
Published inCell metabolism Vol. 24; no. 3; pp. 365 - 367
Main Author Birnbaum, Morris J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 13.09.2016
Subjects
Academic Medical Centers
Communication
Cooperative Behavior
Drug Industry
Humans
Online AccessGet full text
ISSN1550-4131
1932-7420
1932-7420
DOI10.1016/j.cmet.2016.08.026

Cover

More Information
Summary:In recent years, there has been substantial interest in the potential value of collaboration between academia and the pharmaceutical industry. In this Crosstalk, I discuss obstacles to these relationships being optimally productive. In recent years, there has been substantial interest in the potential value of collaboration between academia and the pharmaceutical industry. In this Crosstalk, Birnbaum discusses obstacles to these relationships being optimally productive.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1550-4131
1932-7420
1932-7420
DOI:10.1016/j.cmet.2016.08.026